Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 26 , ISSUE S2 ( October, 2022 ) > List of Articles


Can we Reconcile Evidence-based Medicine with Personalized Medicine: Poised on a Cusp!

Atul Prabhakar Kulkarni, Rajesh Chandra Mishra

Keywords : Aggregated n-of-1 studies, Evidence-based medicine, N-of-1 studies, Personalized medicine, Randomized controlled trials

Citation Information :

DOI: 10.5005/jp-journals-10071-24354

License: CC BY-NC 4.0

Published Online: 31-10-2022

Copyright Statement:  Copyright © 2022; The Author(s).


PDF Share
  1. Sallam HN. Aristotle, godfather of evidence-based medicine. Facts Views Vis Obgyn 2010;2(1):11–19. PMCID: PMC4154333.
  2. Guyatt GH. Evidence-based medicine. ACP J Club 1991;114:A-16. DOI: 10.7326/ACPJC-1991-114-2-A16.
  3. Claridge JA, Fabian TC. History and development of evidence-based medicine. World J Surg 2005;29:547–553. DOI: 10.1007/s00268-005-7910-1.
  4. Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA 1992;268(17):2420–2425. DOI: 10.1001/jama.1992.03490170092032.
  5. Institute of Medicine (US) Committee to Advise the Public Health Service on Clinical Practice Guidelines. Clinical Practice Guidelines: Directions for a New Program. Field MJ, Lohr KN, editors. Washington (DC): National Academies Press (US); 1990.
  6. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines. BMJ 1999;318(7182):527–530. DOI: 10.1136/bmj.318.7182.527.
  7. Sackett DL. Evidence-based medicine. Semin Perinatol 1997;21(1): 3–5. DOI: 10.1016/s0146-0005(97)80013-4.
  8. Diringer E, Yende S. Protocol-directed care in the ICU: Making a future generation of intensivists less knowledgeable? Crit Care 2012;16(2):307. DOI: 10.1186/cc11257.
  9. Vogenberg FR, Isaacson Barash C, Pursel M. Personalized medicine: Part 1: Evolution and development into theranostics. P T 2010;35(10):560–576. PMID: 21037908.
  10. Giamarellos-Bourboulis EJ, Opal SM. The role of genetics and antibodies in sepsis. Ann Transl Med 2016;4(17):328. DOI: 10.21037/atm.2016.08.63.
  11. Georgescu AM, Banescu C, Azamfirei R, Hutanu A, Moldovan V, Badea I, et al. Evaluation of TNF-α genetic polymorphisms as predictors for sepsis susceptibility and progression. BMC Infect Dis 2020;20(1):221. DOI: 10.1186/s12879-020-4910-6.
  12. Montoya-Ruiz C, Jaimes FA, Rugeles MT, López JÁ, Bedoya G, Velilla PA. Variants in LTA, TNF, IL1B and IL10 genes associated with the clinical course of sepsis. Immunol Res 2016;64(5–6):1168–1178. DOI: 10.1007/s12026-016-8860-4.
  13. Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med 2010;363(4):301–304. DOI: 10.1056/NEJMp1006304.
  14. Schork NJ. Randomized clinical trials and personalized medicine: A commentary on deaton and cartwright. Soc Sci Med 2018;210: 71–73. DOI: 10.1016/j.socscimed.2018.04.033.
  15. Lillie EO, Patay B, Diamant J, Issell B, Topol EJ, Schork NJ. The n-of-1 clinical trial: the ultimate strategy for individualizing medicine? Per Med 2011;8(2):161–173. DOI: 10.2217/pme.11.7.
  16. Blackston JW, Chapple AG, McGree JM, McDonald S, Nikles J. Comparison of aggregated n-of-1 trials with parallel and crossover randomized controlled trials using simulation studies. Healthcare (Basel) 2019;7(4):137. DOI: 10.3390/healthcare7040137.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.